Trial
NCT02893826
Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Edge Therapeutics Inc
Collaborators
—
Condition
Subarachnoid Hemorrhage, Aneurysmal
Intervention
EG-1962 (nimodipine microparticles)
Why stopped
Based on DMC recommendation to discontinue EG-01-1962-03
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-26